Why the study?
The guideline was developed to translate scientific evidence into recommendations on blood cholesterol management to improve cardiovascular health and quality of care for patients with or at risk of cardiovascular disease.
Population
Patients with or at risk of developing CVD
Design
Clinical practice guideline
Authors
Loading...
Directs cholesterol management to reduce ASCVD risk; reinforces consensus on structured recommendations and shared decision-making.
Provides the 2018 ACC/AHA clinical practice guidelines for the management of blood cholesterol to reduce atherosclerotic cardiovascular disease risk.
Grundy et al. (2019) studied this question. The 2018 AHA/ACC guidelines aim to improve cardiovascular care and patient outcomes through structured recommendations and shared decision-making.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: